Compare Stocks

Back to Screener

Select Stocks to Compare

Add or remove up to 5 stocks to perform stock analysis, comparing market price, stock performance, and financial statements for informed decisions.

Stock Comparison Charts

Metric
Sequent Scientific Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Eris Lifesciences Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Divi's Laboratories Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Laurus Labs Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Stock Details
Current Price 188.09 1702.0 6930.0 768.2
Previous Close 185.89 1718.6 6876.0 758.55
Open 187.3 1710.0 6880.0 759.8
Day Low 185.01 1686.1 6870.0 756.65
Day High 189.01 1716.7 6939.5 770.2
Market Cap 47550840832.0 236831588352.0 1839700115456.0 414693588992.0
P/E Ratio 221.28 66.05 84.19 115.35
Forward P/E 37.25 40.86 123.09 32.87
Earnings Per Share 0.85 25.77 82.31 6.66
Dividend Yield (%) N/A 0.87 0.44 0.22
Beta 1.12 -0.01 0.34 0.76
EBITDA 1588600064.0 10172000256.0 29680001024.0 10341900288.0
Book Value 27.97 209.88 563.71 82.94
Debt to Equity 62.47 75.74 0.03 60.05
ROCE (%) N/A N/A N/A N/A
ROE (%) N/A N/A N/A N/A
Face Value N/A N/A N/A N/A
Price to Book 6.73 8.11 12.29 9.26
Performance
1Y Return (%) 4115.73 6983.05 4851.93 5897.52
About Company
Founded Year N/A N/A N/A N/A
Employees N/A N/A N/A 6167
Website Live Website of SEQUENT Live Website of ERIS Live Website of DIVISLAB Live Website of LAURUSLABS

Company Overviews & Financial Position

Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.

Sequent Scientific Limited

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.

Eris Lifesciences Limited

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.